HeartFlow NovoCure: Which Emerging Stock Is Best in 2026
HeartFlow and NovoCure represent two very different paths to modernizing care. One targets non invasive CAD diagnosis...
This guide compares risk profiles of index funds and bonds in retirement, helping you choose allocations that align with your comfort and goals.
28,591 articlesHeartFlow and NovoCure represent two very different paths to modernizing care. One targets non invasive CAD diagnosis...
As Torrid approaches its 2026 earnings moment, investors seek signals on growth, margins, and the road to improved pr...
A premium fitness brand attracts a substantial fund investment while its stock lags. This piece breaks down what it m...
SoFi Technologies has dropped about 42% over the last six months, trading near $16 as market conditions tighten. Anal...
A lithium-extraction startup says its new method triples recovery while shortening timelines, accelerating toward com...
JPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...
Shield AI just unveiled a landmark Series G round worth $1.5 billion, lifting its valuation to $12.7 billion and sett...
Public disclosures show a former president engaged in a rapid trading spree in the first quarter, totaling 3,600 stoc...
Strategy disclosed a record unrealized loss on its Bitcoin holdings, topping $10 billion as bitcoin trades near $61,0...
Four billionaire investors from divergent strategies quietly increased bets on a leading chipmaker, signaling a broad...
Bitcoin has slid to around 60K in six weeks, wiping out years of gains. This piece examines this hidden reason behind...
Retail traders who chased celebrity-backed crypto deals tied to a high-profile political name are confronting losses ...